跳至主要内容
临床试验/NCT01128166
NCT01128166已完成不适用

Multisensor Chronic Evaluations in Ambulatory Heart Failure Patients

Boston Scientific Corporation99 个研究点 分布在 1 个国家目标入组 975 人开始时间: 2010年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
975
试验地点
99
主要终点
Heart Failure (HF) events

研究概览

简要总结

The goal of the MultiSENSE study is to collect chronic information from multiple sensors in an implanted device for evaluation in heart failure patients.

详细描述

The purpose of MultiSENSE study is to collect data about patient events during worsening heart failure, determine how sensor measurements vary during patient daily activities and during the development and recovery from events of worsening heart failure, develop algorithms capable of detecting the onset of worsening heart failure prior to the overt presentation of patient symptoms using reference measurements: thoracic impedance, heart sounds, physiologic responses to activities and respiration.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age 18 or above, or of legal age to give informed consent specific to state and national law
  • •Willing and capable of returning for all follow-up visits and emergency care at the investigational center as medically appropriate
  • •Willing to participate in all testing associated with this clinical investigation at an approved clinical investigational center
  • •Currently implanted with a COGNIS device (Model N119 or N120, P107, P108)
  • •Classified as NYHA Class II, III or IV within the last six months

排除标准

  • •Inability or refusal to sign the Subject Informed Consent
  • •Inability of refusal to comply with the follow-up schedule
  • •Documented as pacemaker dependent
  • •Unable to rest comfortably in a semi-recumbent position for up to 20 minutes
  • •Implanted with active Medtronic Fidelis lead models: 6930, 6931, 6948 or 6949
  • •Currently implanted with unipolar RA, RV, or LV leads
  • •LV sensitivity programmed to less than 0.7 mV AGC
  • •History of appropriate tachycardia therapy (external or implanted) for rates < 165 bpm within 1 week prior to enrollment
  • •Device battery status indicates approximate time to explant < 2 years
  • •Likely to undergo lead or PG revision during the course of the study as determined by the investigator
  • •Receiving regularly scheduled intravenous (IV) inotropic therapy as part of their drug regimen
  • •Have received heart or lung transplant
  • •Receiving mechanical circulatory support
  • •Patients who have been referred or admitted for Hospice care
  • •A life expectancy of less than 12 months per physician discretion
  • •Enrolled in any concurrent study without Boston Scientific written approval
  • •Devices previously converted to the SRD-1 and withdrawn from the study
  • •Received a sub-pectoral COGNIS implant prior to February 1, 2011 with a dash number listed in Appendix K of the study protocol
  • •Known pregnancy or plan to become pregnant within the course of the study
  • •LV offset is programmed to a value greater than zero

结局指标

主要结局

Heart Failure (HF) events

时间窗: 12 Months

The primary objectives of this study are to determine how ambulatory sensor measurements change with worsening heart failure, and to develop multisensor detection algorithms. Additional data will be collected to compare sensor measurements against reference measurements when the subject is hospitalized for HF. Data from this study may also be used for determining prospective endpoints and sample sizes for future studies. There are no formal statistical primary or secondary endpoints defined for this study. Therefore, no formal tests of hypothesis will be conducted.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (99)

Loading locations...

相似试验